comparemela.com

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India

thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Helsinki ,Eteläuomen Läi ,Finland ,United States ,India ,United Kingdom ,Pune ,Maharashtra ,Stephen Hill ,Ashfield Medcomms ,Prakash Bhuyan ,Jayaprakash Muliyil ,Nicholas White ,Charudatta Vaman Joglekar ,Oommen John ,Serum Institute Of India Pvt Ltd ,National Institute Of Allergy ,Astrazeneca Pharmaceuticals ,Ashfield Health ,Symbiosis Pharmaceuticals Ltd ,Astrazeneca ,International Council For Harmonisation ,Us Department Of Health ,International Reference Standard ,Protocol Safety Review Team ,University Of Oxford ,National Institutes Of Health ,Human Services ,Placebo Serum Institute Of India Pvt Ltd ,Indian Council Of Medical Research ,Research Institute ,Jenner Institute Laboratories ,International Standard ,Serum Institute ,India Pvt Ltd ,Indian Council ,Drugs Controller General ,Good Clinical Practice ,International Council ,Medical Research ,New Drugs ,Clinical Trial Rules ,Interactive Web Response ,Batch Number ,Pediatric Adverse Events ,National Institutes ,National Institute ,Data Safety Monitoring Board ,Reference Standard ,Antis Igg ,

comparemela.com © 2020. All Rights Reserved.